Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction

Ahmed HMA, Abohamad S, Elfishawi M, Hegazy MT, Vijaykumar K

Patient Preference and Adherence 2018, 12:2475-2479

Published Date: 21 November 2018